Characterization of Cisplatin-Resistant Mechanism in Human Urothelial Carcinoma Cells
碩士 === 高雄醫學大學 === 生物化學研究所碩士班 === 95 === Cisplatin is one of the most effective anticancer drugs used for treatment of solid tumors, including ovarian, small cell lung and bladder cancers. During the cisplatin treatment of urothelial cancer, some patients will become to be cisplatin resistance, and t...
Main Authors: | Ching-I Kuan, 官靜儀 |
---|---|
Other Authors: | Tzyh-Chyuan Hour |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/26893481804969862222 |
Similar Items
-
Mechanism of Cisplatin-Induced Cytotoxicity and Cisplatin Resistance in Human Urothelial Carcinoma Cells
by: Yu, Hui-Min, et al.
Published: (2012) -
Molecular Mechanism of Combining Cisplatin and Aspirin on Human Urothelial Cell Carcinoma and Cisplatin-Resistant Sublines
by: Mei-Chen Chen, et al.
Published: (2015) -
Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines
by: Margaretha A. Skowron, et al.
Published: (2018-02-01) -
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
by: Lena Berning, et al.
Published: (2021-02-01) -
The role of USP2a in cisplatin responsiveness in human urothelial carcinoma cells
by: Yu-An Lee, et al.
Published: (2015)